AJP - Regu Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 287: R386-R390, 2004. First published April 29, 2004; doi:10.1152/ajpregu.00214.2004
0363-6119/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/R386    most recent
00214.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, T.
Right arrow Articles by Chaudry, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, T.
Right arrow Articles by Chaudry, I. H.

INFLAMMATION AND CYTOKINES

Salutary effects of androstenediol on cardiac function and splanchnic perfusion after trauma-hemorrhage

Tomoharu Shimizu, Mashkoor A. Choudhry, Laszlo Szalay, Loring W. Rue, III, Kirby I. Bland, and Irshad H. Chaudry

Center for Surgical Research and Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama 35294

Submitted 31 March 2004 ; accepted in final form 23 April 2004


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Recent studies have shown that dehydroepiandrosterone (DHEA) administration after trauma-hemorrhage (T-H) improves cardiovascular function and decreases cytokine production in male animals. Although androstenediol, one of the metabolites of DHEA, is reported to have estrogen-like activity, it remains unknown whether androstenediol per se has any salutary effects on cytokines and cardiovascular function after T-H. To examine this effect, male Sprague-Dawley rats underwent laparotomy and were bled to and maintained at a mean arterial blood pressure of 35–40 mmHg for ~90 min. The animals were resuscitated with four times the volume of maximal bleedout volume in the form of Ringer lactate. Androstenediol (1 mg/kg body wt iv) or vehicle was administered at the end of resuscitation. Twenty-four hours after resuscitation, cardiac function and organ blood flow were measured by using 85Sr-microspheres. Circulating levels of nitrate/nitrite and IL-6 were also determined. Cardiovascular function and organ blood flow were significantly depressed after T-H. However, these parameters were restored by androstenediol treatment. The elevated plasma IL-6 levels after T-H were also lowered by androstenediol treatment. In contrast, plasma levels of nitrate/nitrite were the highest in the androstenediol-treated T-H animals. Because androstenediol administration after T-H decreases cytokine production and improves cardiovascular function, this agent appears to be a novel and useful adjunct for restoring the depressed cardiovascular function and for cytokine production in males after adverse circulatory conditions.

hemorrhagic shock; nitric oxide; nitric oxide synthase; adiol; 5-androstene-3{beta},17{beta}-diol

HEMORRHAGIC SHOCK results in a rapid decrease in cardiac output and organ blood flow. Furthermore, studies have shown that intestinal perfusion remains depressed even after the recovery of cardiac output by fluid resuscitation (29). This splanchnic hypoperfusion after hemorrhagic shock also activates the inflammatory cascade. The depressed cardiovascular function and excess production of inflammatory mediators play an important role in the development of multiple organ failure after hemorrhagic shock (20).

Previous work from our laboratory has shown that left ventricular performance, cardiac output, and organ blood flow in the liver, small intestine, and kidney decreased significantly after trauma-hemorrhage (3, 4, 25), and plasma levels of IL-6 were elevated under those conditions in male animals (1, 25). However, clinical and laboratory studies have shown that gender differences exist in the organ and immune function after hemorrhagic shock (13, 23, 31). In this regard, our previous studies have shown that male sex steroids have deleterious effects and female sex steroids produce beneficial effects on cardiovascular functions after trauma-hemorrhage (5, 16, 31). In particular, studies have shown that administration of a single dose of estrogen after trauma and hemorrhagic shock improved cardiovascular and hepatocellular functions (18, 25). In addition, dehydroepiandrosterone (DHEA) is the most abundant steroid hormone in plasma and is an intermediate in the pathway for the synthesis of testosterone and estrogen. DHEA treatment after trauma-hemorrhage has been reported to improve organ functions and normalize cytokine production after circulatory stress (9, 15).

Androstenediol (adiol or 5-androstene-3{beta},17{beta}-diol) is one of the metabolites of DHEA. Androstenediol has been reported to have greater protective effects than DHEA against lethal bacterial infections and endotoxin shock (7). Furthermore, androstenediol has also been reported to produce protective effects after ionizing radiation in mice (21, 34). These studies have shown a significant improvement in survival of mice treated with androstenediol after whole body ionizing irradiation with gamma rays. The estrogen-like activities of androstenediol are observed at physiological concentration in breast cancer cells. Androstenediol causes an increase in estrogen receptor-dependent {beta}-galactosidase activity in yeast (26). Furthermore, Schmidt et al. (30) reported the conversion of DHEA to downstream steroid hormones in macrophages. These investigators suggested that the conversion of DHEA leads to an increase of downstream effecter hormones in macrophages that may play an important role in local immunomodulation (30).

Previous studies indicate that vascular endothelial cell dysfunction occurs early after trauma-hemorrhage and may contribute to further alterations in tissue perfusion and cellular function (33). Angele et al. (2) demonstrated that L-arginine (i.e., the substrate for constitutive nitric oxide synthase, cNOS) restored the depressed cardiac output and organ blood flow and decreased plasma levels of IL-6 (2). Recently, androstenediol has been reported to increase nitric oxide synthase (NOS) activity in the vagina of ovariectomized rabbits (32).

Although androstenediol has been reported to produce the above-mentioned salutary effects, it remains unknown whether this metabolite or its parent compound is responsible for producing the salutary effects after trauma-hemorrhage. We hypothesized that androstenediol itself is a useful adjunct for improving the depressed cardiovascular function and cytokine production after trauma-hemorrhage. To test this hypothesis, we examined whether administration of androstenediol has any salutary effects on cardiovascular function and cytokine production in males after trauma-hemorrhage. In addition, plasma levels of nitrate/nitrite were determined to evaluate systemic nitric oxide production.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals. Adult male (275–325 g) Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) were used in this study. All experiments were performed in adherence to the National Institutes of Health Guidelines for the Use of Experimental Animals and approved by the Institutional Animal Care and Use Committee of the University of Alabama at Birmingham.

Experimental procedures. A nonheparinized model of trauma-hemorrhage in the rat, as previously described, was used in this study (31). Briefly, male Sprague-Dawley rats (275–325 g) were fasted overnight before the experiment but allowed water ad libitum. The rats were anesthetized by isoflurane (Attane, Minrad, Bethlehem, PA) inhalation before the induction of soft tissue trauma (i.e., 5-cm midline laparotomy). The abdomen was then closed in layers, and catheters were placed in both femoral arteries and the right femoral vein [polyethylene (PE-50) tubing; Becton-Dickinson, Sparks, MD]. The animals were then restrained in a supine position, and the wounds were bathed with 1% lidocaine (Elkins-Sinn, Cherry Hill, NJ) throughout the surgical procedure to minimize postoperative pain. The rats were then allowed to awaken, after which they were bled to a mean arterial pressure (MAP) of 35–40 mmHg within 10 min. The time at which the animals could no longer maintain an MAP of 35–40 mmHg without infusing some fluid was defined as maximum bleed-out volume. The rats were maintained at this MAP until 40% of the shed blood was returned in the form of Ringer lactate. The animals were then resuscitated with four times the volume of shed blood with Ringer lactate over 60 min. After resuscitation, the catheters were removed, the vessels were ligated, and skin incisions were closed with sutures. Sham-operated animals underwent the same groin dissection, which included the ligation of the femoral artery, and catheters were placed in the femoral vein to administer agents; however, neither trauma-hemorrhage nor resuscitation was carried out. The animals were returned to their cages and were allowed food and water ad libitum until death. The animals were killed at 24 h after the end of resuscitation.

In the treatment group, 1 mg/kg body wt androstenediol (Steraloids, Newport, RI) was administered intravenously at the end of the resuscitation. In the vehicle-treated group (control group) rats received the same volume of vehicle (Intralipid, 1 ml/kg body wt, Sigma, St. Louis, MO).

Measurement of plasma levels of nitrate/nitrite. Blood samples were obtained and placed in microcentrifuge tubes at 24 h after the end of resuscitation or sham operation, and plasma was separated by the centrifugation, immediately frozen, and stored at –80°C until assayed. The production of systemic nitric oxide was evaluated by measuring plasma nitrate/nitrite levels using a commercially available colorimetric assay kit (Cayman Chemical, Ann Arbor, MI).

Measurement of plasma levels of IL-6. Plasma levels of IL-6 were determined using ELISA kits (Pharmingen, San Diego, CA) according to the manufacturer's instructions.

Measurement of heart performance, cardiac output, and organ blood flow. In an additional set of animals, heart performance was evaluated at 24 h after resuscitation or sham operation, as previously described (4). Briefly, rats were anesthetized with pentobarbital sodium (~30 mg/kg body wt), and a PE-50 catheter was inserted into the left ventricle via right carotid artery. The maximal rates of left ventricular pressure increase (+dP/dtmax) and decrease (–dP/dtmax) were determined with a heart performance analyzer.

Cardiac output and organ blood flow in the small intestine, liver, spleen, kidney, pancreas, adrenal grand, brain, heart, and lung were determined by using a radioactive microsphere technique as previously described (4). Briefly, 85Sr-labeled microspheres (~500,000 cpm; DuPont NEN, Boston, MA) were injected manually into the left ventricle. The reference blood sample was withdrawn from the femoral arterial catheter for 60 s at a rate of 0.7 ml/min. Isotonic sodium chloride solution was infused at the same rate to replace the volume of blood lost. The animals were killed, and abdominal organs were then harvested and weighed. The radioactivity in the organs and reference blood sample was counted with an automatic gamma counter (1470 Wizard; Wallac, Gaithersburg, MD). Cardiac output and organ blood flow were calculated according to the following two equations: 1) cardiac output = [(RBF x CT)/Cr] x 100/BW, and 2) organ blood flow = [(RBF x Ct)/Cr] x 100, where RBF is the reference blood sample withdrawal rate (0.7 ml/min), CT is counts per minute of total injected dose, Cr is counts per minute in the reference blood sample, BW is body weight (g), and Ct is counts per minute per gram of tissue.

Statistical analysis. Data are presented as means ± SE. Statistical differences between groups were determined by one-way ANOVA followed by Fisher's least significant difference as a post hoc test. The differences were considered significant if P < 0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Alterations in hemodynamic parameters. There was no significant difference in the hemodynamic parameters between androstenediol-treated and nontreated sham-operated animals. As shown in Fig. 1, cardiac output significantly decreased in vehicle-treated rats after trauma-hemorrhage. Androstenediol treatment after trauma-hemorrhage increased cardiac output, and the values were similar to those observed in sham-operated animals (Fig. 1A). Furthermore, the positive and negative dP/dtmax shown in Fig. 1, B and C, were also significantly depressed at 24 h after trauma-hemorrhage. Treatment of rats with androstenediol prevented the decrease in positive dP/dtmax and negative dP/dtmax; however, negative dP/dtmax was still significantly lower than in sham-operated animals (Fig. 1, B and C).



View larger version (32K):
[in this window]
[in a new window]
  		Fig. 1. Effects of androstenediol (adiol) on cardiac output (A) and maximal rate of pressure increase (+dP/dtmax; B) and decrease (–dP/dtmax; C) in the left ventricle at 24 h after sham operation or trauma-hemorrhage (T-H). Data are presented as means ± SE (n = 6 animals/group). *P < 0.05 vs. other groups, #P < 0.05 vs. sham operated-adiol.

 
Mean blood pressure also decreased significantly in rats after trauma-hemorrhage (Fig. 2A). Treatment of rats with androstenediol after trauma-hemorrhage did not significantly improve mean blood pressure compared with vehicle-treated trauma-hemorrhaged animals. Furthermore, no significant difference in heart rate was observed among the different groups of animals (Fig. 2B).



View larger version (42K):
[in this window]
[in a new window]
  		Fig. 2. Effects of androstenediol on mean blood pressure (A) and heart rate (B) at 24 h after sham operation or trauma-hemorrhage. Data are presented as means ± SE (n = 6 animals/group): *P < 0.05 vs. sham operated.

 
Alteration in organ blood flow. There was no difference in organ blood flow between androstenediol- and vehicle-treated sham-operated groups (Table 1). Trauma-hemorrhage markedly decreased blood flow in the small intestine, liver, spleen, kidney, pancreas, and adrenal gland of the vehicle-treated rats. Androstenediol treatment after trauma-hemorrhage prevented the decrease in blood flow in the small intestine and liver. Furthermore, although androstenediol treatment after trauma-hemorrhage increased blood flow in the spleen, kidney, and pancreas, it was not restored to normal in these organs (Table 1). Androstenediol treatment did not improve blood flow in the adrenal gland. However, blood flow in the brain increased significantly in both the vehicle- and androstenediol-treated rats after trauma-hemorrhage. There was no significant difference in blood flow in the heart and lung among the different group of animals (Table 1).


View this table:
[in this window]
[in a new window]
  		Table 1. Organ blood flow after trauma-hemorrhage

 
Plasma levels of nitrate/nitrite. Plasma levels of nitrate/nitrite increased significantly at 24 h after trauma-hemorrhage. Androstenediol treatment further increased nitrate/nitrite levels in rats after trauma-hemorrhage (Fig. 3), but it did not influence the nitrate/nitrite levels in the sham-operated rats.



View larger version (22K):
[in this window]
[in a new window]
  		Fig. 3. Plasma levels of nitrate/nitrite at 24 h after sham operation or trauma-hemorrhage. Data are presented as means ± SE (n = 6 animals/group). *P < 0.05 vs. other groups, #P < 0.05 vs. sham operated.

 
Plasma IL-6 levels. Plasma IL-6 levels were significantly elevated after trauma-hemorrhage compared with sham-operated rats in the vehicle treatment group. However, androstenediol treatment markedly decreased the levels of IL-6 after trauma-hemorrhage (Fig. 4).



View larger version (14K):
[in this window]
[in a new window]
  		Fig. 4. Effects of androstenediol on plasma IL-6 levels at 24 h after sham operation or trauma-hemorrhage. Data are means ± SE (n = 6 animals/group). *P < 0.05 vs. other groups.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
The present study showed that administration of androstenediol after trauma-hemorrhage improved left ventricular performance, cardiac output, and organ blood in the small intestine, liver, spleen, and kidney. This improvement of cardiovascular function was associated with increase of plasma nitrate/nitrite levels. Furthermore, elevated circulating levels of IL-6 after trauma-hemorrhage were significantly reduced by androstenediol treatment.

Gender dimorphism was observed in the cardiac function and tissue perfusion after trauma-hemorrhage. Previous studies from our laboratory have shown that proestrus female rats, which have high circulating levels of estrogen and progesterone, maintain cardiac output and higher splanchnic perfusion compared with male rats after trauma-hemorrhage (3). Our previous studies have also shown that administration of a single dose of estrogen after trauma-hemorrhage improved cardiovascular and hepatocellular functions (18, 25). Alternatively, testosterone receptor blockade after trauma-hemorrhage by flutamide in normal male rats restored the depressed cardiac function, blood flow, oxygen delivery, and consumption in all organs tested (5). Additionally, Jarrar et al. (15) demonstrated that DHEA administration after trauma-hemorrhage restored the depressed cardiac and hepatocellular functions in male rats. DHEA is the most abundant steroid hormone in plasma and is an intermediate in the pathway for the synthesis of testosterone and estrogen. The salutary effects of DHEA were not observed if the estrogen receptor antagonist ICI-182780 was administered with DHEA. However, plasma levels of 17{beta}-estradiol and testosterone were not significantly altered in animals receiving DHEA (15). Thus the above studies collectively suggest that gender dimorphism does exist in the cardiac function and tissue perfusion after trauma-hemorrhage.

In this study, we examined the effect of androstenediol on cardiac functions after trauma-hemorrhage because androstenediol is one of the metabolites of DHEA. This agent has been reported to have protective effects against lethal bacterial infections and endotoxin shock. The results presented in this manuscript clearly suggest that treatment of rats with single dose of androstenediol (1 mg/kg iv) after trauma-hemorrhage significantly improved cardiac function, prevented the elevation in IL-6, and further increased nitrate/nitrite levels under those conditions. Whether androstenediol increases endothelial NOS (eNOS) and whether this increase is responsible for the elevated nitrate/nitrite levels remains to be determined. It should be pointed out, however, that the dose of androstenediol that was used in this study did not restore blood flow in some organs. Whether androstenediol at higher doses or repeat treatment would restore blood flow to those organs remains unknown. We did not use a higher dose of androstenediol or repeat treatment because a number of potential risk factors associated with higher dose and long-term androstenediol use have been reported (34). Long-term oral supplementation with androstenediol appears to adversely affect blood lipids (i.e., decrease of high-density lipoprotein concentration) and increase the risk of pancreatic cancer or prostate cancer (8). Nonetheless, our findings suggest that administration of a single dose (1 mg/kg iv) of androstenediol as an adjunct to resuscitation after trauma-hemorrhage is effective for restoring and maintaining cardiovascular function and cytokine production after trauma-hemorrhage.

The precise mechanism responsible for producing the beneficial effects of androstenediol on cardiac function and organ blood flow is not known. Nonetheless, several studies have shown that hemorrhagic shock induces a cascade of proinflammatory cytokines that are associated with immunosuppression (12), hemodynamic depression, and organ dysfunction (6). In this regard, studies by Mizushima et al. (25) have shown that administration of estrogen after trauma-hemorrhage reduced circulating levels of IL-6. Knoferl et al. (17) also reported that administration of DHEA after trauma-hemorrhage significantly reduced the elevated circulating IL-6 levels, suggesting an attenuation of the inflammatory response under those conditions. Furthermore, Kuebler et al. (19) have demonstrated that progesterone treatment after trauma-hemorrhage also significantly reduces plasma IL-6 levels (19). Consistent with these findings, the present findings also indicate that the elevated circulating levels of IL-6 after trauma-hemorrhage were significantly reduced by androstenediol treatment. Because elevated levels of IL-6 have been correlated with cardiac dysfunction in many injury conditions (14, 22) as well as after trauma-hemorrhage (17, 19, 25), it is likely that attenuation of IL-6 production could be a factor responsible for androstenediol salutary effect in preventing cardiac dysfunction after trauma-hemorrhage.

In addition to IL-6, we also found an increase in nitrate/nitrite production after trauma-hemorrhage, and treatment with androstenediol further elevated systemic nitrate/nitrite levels. Eckhoff et al. (11) have shown that estrogen administration significantly reduced hepatic injury after ischemia-reperfusion to the liver, and this effect was associated with increased serum nitric oxide metabolites. Our result showed further induction of nitrate/nitrite in the androstenediol-treated rats. Although we have not determined whether the increase in nitrate/nitrite levels is due to inducible NOS or cNOS, it is likely that the increase in NOS, especially eNOS activity in androstenediol-treated animals, may contribute to the improvement of cardiac output and splanchnic perfusion after trauma-hemorrhage.

Several studies have shown salutary effects of androstenediol treatment on immune functions after injury such as endotoxin shock, sepsis, and radiation injury (7, 21, 34). Ben-Nathan et al. (7) reported that androstenediol had greater protective effects on survival rate than DHEA against lethal bacterial infections and endotoxin shock. In contrast, Padgett and Loria (28) have shown that androstenediol had little influence on the secretion of LPS-induced proinflammatory cytokine (IL-6, TNF-{alpha}, and IL-1) from macrophages in vitro. Whether the difference in the results of Ben-Nathan et al. (7) and Padgett and Loria (28) is due to in vivo vs. in vitro use of DHEA remains unclear.

Although the precise mechanism responsible for the beneficial effects of androstenediol on cytokine production remains unknown, it is possible that androstenediol mediates its action via the estrogen receptor(s). In this regard, several studies have shown that estrogens have protective effects on the cardiovascular system via the rapid nongenomic and long-term genomic mechanisms (10, 24). Furthermore, studies have shown that administration of a single dose of estrogen after trauma-hemorrhage improved cardiovascular and hepatocellular functions and splanchnic perfusion (18, 25). Recent study from our laboratory (35) has also shown that estrogen attenuated the production of IL-6 by Kupffer cells from both sham-operated and trauma-hemorrhage animals in a dose-dependent manner. Because Kupffer cells have been reported to be the major source of IL-6 production after trauma-hemorrhage (27), it is likely that similar to estrogen, androstenediol treatment downregulates the production of IL-6 from Kupffer cells. However, further studies are needed to determine such a paradigm.

In summary, our study indicates that androstenediol administration after trauma-hemorrhage improves cardiac function and organ blood flow and decreases cytokine production. This improvement of cardiovascular function may be associated with attenuation in IL-6 levels and an increase in plasma nitrite/nitrate levels. Because androstenediol produced the above-mentioned salutary effect, these results lead us to conclude that androstenediol appears to be a useful adjunct for restoring the depressed cardiovascular functions and attenuating cytokine production after trauma-hemorrhage.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This investigation was supported by National Institutes of Health Grant R37-GM-39519.


   ACKNOWLEDGMENTS
 
We thank Z. F. Ba for superb technical assistance during these studies.


   FOOTNOTES
 

Address for reprint requests and other correspondence: I. H. Chaudry, Center for Surgical Research, Univ. of Alabama at Birmingham, 1670 Univ. Blvd., Volker Hall, Rm. G094, Birmingham, AL 35294-0019 (E-mail: Irshad.Chaudry{at}ccc.uab.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Angele MK, Schwacha MG, Ayala A, and Chaudry IH. Effect of gender and sex hormones on immune responses following shock. Shock 14: 81–90, 2000.[Web of Science][Medline]
  2. Angele MK, Smail N, Wang P, Cioffi WG, Bland KI, and Chaudry IH. L-Arginine restores the depressed cardiac output and regional perfusion after trauma-hemorrhage. Surgery 124: 394–402,1998.[Web of Science][Medline]
  3. Ba ZF, Kuebler JF, Rue 3rd LW, Bland KI, Wang P, and Chaudry IH. Gender dimorphic tissue perfusion response after acute hemorrhage and resuscitation: role of vascular endothelial cell function. Am J Physiol Heart Circ Physiol 284: H2162–H2169, 2003.[Abstract/Free Full Text]
  4. Ba ZF, Wang P, Koo DJ, Cioffi WG, Bland KI, and Chaudry IH. Alterations in tissue oxygen consumption and extraction after trauma and hemorrhagic shock. Crit Care Med 28: 2837–2842, 2000.[CrossRef][Web of Science][Medline]
  5. Ba ZF, Wang P, Koo DJ, Ornan DA, Bland KI, and Chaudry IH. Attenuation of vascular endothelial dysfunction by testosterone receptor blockade after trauma and hemorrhagic shock. Arch Surg 136: 1158–1163, 2001.[Abstract/Free Full Text]
  6. Bahrami S, Yao YM, Leichtfried G, Redl H, Marzi I, and Schlag G. Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol Heart Circ Physiol 272: H2219–H2226, 1997.[Abstract/Free Full Text]
  7. Ben-Nathan D, Padgett DA, and Loria RM. Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol 48: 425–431, 1999.[Abstract/Free Full Text]
  8. Broeder CE. Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits? Can J Appl Physiol 28: 102–116, 2003.[Web of Science][Medline]
  9. Catania RA, Angele MK, Ayala A, Cioffi WG, Bland KI, and Chaudry IH. Dehydroepiandrosterone restores immune function following trauma-haemorrhage by a direct effect on T lymphocytes. Cytokine 11: 443–450, 1999.[CrossRef][Web of Science][Medline]
  10. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, and Shaul PW. Estrogen receptor mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401–406, 1999.[Web of Science][Medline]
  11. Eckhoff DE, Bilbao G, Frenette L, Thompson JA, and Contreras JL. 17{beta}-Estradiol protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-{alpha}. Surgery 132: 302–309, 2002.[CrossRef][Web of Science][Medline]
  12. Ertel W, Morrison MH, Ayala A, Perrin MM, and Chaudry IH. Anti-TNF monoclonal antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression. Immunology 74: 290–297, 1991.[Web of Science][Medline]
  13. George RL, McGwin G Jr, Windham ST, Melton SM, Metzger J, Chaudry IH, and Rue LW III. Age-related gender differential in outcome after blunt or penetrating trauma. Shock 19: 28–32, 2003.[CrossRef][Web of Science][Medline]
  14. Jambrik Z, Gyongyosi M, Hegyi P, Czako L, Takacs T, Farkas A, Mandy Y, Gog C, Glogar D, and Csanady M. Plasma levels of IL-6 correlate with hemodynamic abnormalities in acute pancreatitis in rabbits. Intensive Care Med 28: 1810–1818, 2002.[CrossRef][Web of Science][Medline]
  15. Jarrar D, Wang P, Cioffi WG, Bland KI, and Chaudry IH. Mechanisms of the salutary effects of dehydroepiandrosterone after trauma-hemorrhage: direct or indirect effects on cardiac and hepatocellular functions? Arch Surg 135: 416–423, 2000.[Abstract/Free Full Text]
  16. Jarrar D, Wang P, Cioffi WG, Bland KI, and Chaudry IH. The female reproductive cycle is an important variable in the response to trauma-hemorrhage. Am J Physiol Heart Circ Physiol 279: H1015–H1021, 2000.[Abstract/Free Full Text]
  17. Knoferl MW, Angele MK, Catania RA, Diodato MD, Bland KI, and Chaudry IH. Immunomodulatory effects of dehydroepiandrosterone in proestrus female mice after trauma-hemorrhage. J Appl Physiol 95: 529–535, 2003.[Abstract/Free Full Text]
  18. Kuebler JF, Jarrar D, Toth B, Bland KI, Rue L III, Wang P, and Chaudry IH. Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 137: 74–92, 2002.[Abstract/Free Full Text]
  19. Kuebler JF, Yokoyama Y, Jarrar D, Toth B, Rue LW III, Bland KI, Wang P, and Chaudry IH. Administration of progesterone after trauma and hemorrhagic shock prevents hepatocellular injury. Arch Surg 138: 727–734, 2003.[Abstract/Free Full Text]
  20. Landow L and Andersen LW. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 38: 626–623, 1994.[Web of Science][Medline]
  21. Loria RM. Immune upregulation and tumor apoptosis by androstene steroids. Steroids 67: 953–966, 2002.[CrossRef][Web of Science][Medline]
  22. Maass DL, White J, and Horton JW. IL-1{beta} and IL-6 act synergistically with TNF-{alpha} to alter cardiac contractile function after burn trauma. Shock 18: 360–366, 2002.[CrossRef][Web of Science][Medline]
  23. McKinley BA, Kozar RA, Cocanour CS, Valdivia A, Sailors RM, Ware DN, and Moore FA. Standardized trauma resuscitation: female hearts respond better. Arch Surg 137: 578–583, 2002.[Abstract/Free Full Text]
  24. Mendelsohn ME and Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801–1811, 1999.[Free Full Text]
  25. Mizushima Y, Wang P, Jarrar D, Cioffi WG, Bland KI, and Chaudry IH. Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals. Ann Surg 232: 673–679, 2000.[CrossRef][Web of Science][Medline]
  26. Nephew KP, Sheeler CQ, Dudley MD, Gordon S, Nayfield SG, and Khan SA. Studies of dehydroepiandrosterone (DHEA) with the human estrogen receptor in yeast. Mol Cell Endocrinol 143: 133–142, 1998.[CrossRef][Web of Science][Medline]
  27. O'Neill PJ, Ayala A, Wang P, Ba ZF, Morrison MH, Schultze AE, Reich SS, and Chaudry IH. Role of Kupffer cells in interleukin-6 release following trauma-hemorrhage and resuscitation. Shock 1: 43–47, 1994.[Web of Science][Medline]
  28. Padgett DA and Loria RM. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J Neuroimmunol 84: 61–68, 1998.[CrossRef][Web of Science][Medline]
  29. Scannell G, Clark L, and Waxman K. Regional flow during experimental hemorrhage and crystalloid resuscitation: persistence of low flow to the splanchnic organs. Resuscitation 23: 217–225, 1992.[CrossRef][Web of Science][Medline]
  30. Schmidt M, Kreutz M, Loffler G, Scholmerich J, and Straub RH. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 164: 161–169, 2000.[Abstract]
  31. Toth B, Yokoyama Y, Kuebler JF, Schwacha MG, Rue LW III, Bland KI, and Chaudry IH. Sex differences in hepatic hemeoxygenase expression and activity following trauma and hemorrhagic shock. Arch Surg 138: 1375–1382, 2003.[Abstract/Free Full Text]
  32. Traish AM, Kim NN, Huang YH, Min K, Munarriz R, and Goldstein I. Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina. Int J Impot Res 15: 397–404, 2003.[CrossRef][Web of Science][Medline]
  33. Wang P, Ba ZF, and Chaudry IH. Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. Am J Physiol Heart Circ Physiol 265: H973–H979, 1993.[Abstract/Free Full Text]
  34. Whitnall MH, Wilhelmsen CL, McKinney L, Miner V, Seed TM, and Jackson WE III. Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharmacol Immunotoxicol 24: 595–626, 2002.[CrossRef][Web of Science][Medline]
  35. Yokoyama Y, Kuebler JF, Matsutani T, Schwacha MG, Bland KI, and Chaudry IH. Mechanism of the salutary effects of 17beta-estradiol following trauma-hemorrhage: direct downregulation of Kupffer cell proinflammatory cytokine production. Cytokine 21: 91–97, 2003.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
J. G. Kiang, R. M. Peckham, L. E. Duke, T. Shimizu, I. H. Chaudry, and G. C. Tsokos
Androstenediol inhibits the trauma-hemorrhage-induced increase in caspase-3 by downregulating the inducible nitric oxide synthase pathway
J Appl Physiol, March 1, 2007; 102(3): 933 - 941.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Szalay, T. Shimizu, T. Suzuki, Y.-C. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry
Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis
Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G260 - G266.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Shimizu, L. Szalay, M. A. Choudhry, M. G. Schwacha, L. W. Rue III, K. I. Bland, and I. H. Chaudry
Mechanism of salutary effects of androstenediol on hepatic function after trauma-hemorrhage: role of endothelial and inducible nitric oxide synthase
Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G244 - G250.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/R386    most recent
00214.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, T.
Right arrow Articles by Chaudry, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, T.
Right arrow Articles by Chaudry, I. H.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.